FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080802 [Registered on: 18/02/2025] Trial Registered Prospectively
Last Modified On: 04/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing the effects of two anesthesia drugs, etomidate and propofol, on blood pressure during induction for General anaesthesia in patients undergoing liver transplant surgery 
Scientific Title of Study   Effect of etomidate versus propofol on hemodynamic parameters for induction in recipients undergoing liver transplant surgery: a randomized control trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ishan Verma 
Designation  Senior Resident 
Affiliation  Institute Of Liver and Biliary Sciences 
Address  Institute of Liver and Biliary Sciences, Department Of Anaesthesia, phase2, Anaesthesia classroom ,room1 ,Vasant Kunj New Delhi

New Delhi
DELHI
110070
India 
Phone  7987340168  
Fax    
Email  ishanverma8653@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anil Yadav 
Designation  Assistant Professor 
Affiliation  Institute Of Liver and Biliary Sciences 
Address  Institute of Liver and Biliary Sciences, Department Of Anaesthesia, Academic Block room 4 ,Vasant Kunj , New Delhi

New Delhi
DELHI
110070
India 
Phone  8089337600  
Fax    
Email  doc.anilyadav@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Anil Yadav 
Designation  Assistant Professor 
Affiliation  Institute Of Liver and Biliary Sciences 
Address  Institute of Liver and Biliary Sciences, Department Of Anaesthesia, Academic Block room 4 ,Vasant Kunj , New Delhi

New Delhi
DELHI
110070
India 
Phone  8089337600  
Fax    
Email  doc.anilyadav@gmail.com  
 
Source of Monetary or Material Support  
Institute of Liver and Biliary Sciences, Vasant Kunj , New Delhi,India. PIN code-110070 
 
Primary Sponsor  
Name  Institute of Liver and Biliary Sciences 
Address  Institute of Liver and Biliary Sciences, Vasant Kunj , New Delhi,India. PIN code-110070 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ishan Verma  Institute of liver and biliary sciences  Institute of liver and biliary sciences, Vasant Kunj Delhi
New Delhi
DELHI 
7987340168

ishanverma8653@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTE OF LIVER AND BILIARY SCIENCES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Etomidate  Etomidate as induction agent Dose: 0.2 to 0.3 mg per kg Frequency: Once Route: intravenous Duration: once 
Comparator Agent  Propofol  Propofol as induction agent Dose: 2 to 3 mg per kg Frequency: Once Route: intravenous Duration: once 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Age 18 to 60 years Patients undergoing Liver Transplant Recipient Surgery 
 
ExclusionCriteria 
Details  Patients who do not consent for the study.
Recipients for Acute liver failure and acute on chronic liver failure
Patients with preexisting cardiac disease
Patients with Cirrhotic Cardiomyopathy
Patients having allergy to propofol or etomidate 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To study change in mean arterial pressure during induction every minute till 10
minutes. 
10 minutes 
 
Secondary Outcome  
Outcome  TimePoints 
To compare hemodynamic parameters: HR-heart rate, SBP- systolic blood pressure, DBP- Diastolic blood pressure, CO- cardiac output, SV- stroke volume, SVV- Stroke volume variation during induction every minute till 10 minutes.
 
10 minutes after induction 
To compare use of vasopressor during induction every minute till 10 minutes.
 
10 minutes after induction 
To compare rate of complication like myoclonus and pain on injection during induction every minute till 10 minutes.  10 minutes after induction 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "55"
Final Enrollment numbers achieved (India)="55" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   10/03/2025 
Date of Study Completion (India) 15/05/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 15/05/2025 
Estimated Duration of Trial   Years="0"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Hypothesis : Etomidate will give better hemodynamic stability as induction agent than propofol
Study population: Patients will be assigned to two groups of 25 each.


Group A (n=25) (Induction with Propofol)
Group B (n=25) (Induction with Etomidate)
Study design: Prospective randomized controlled trial
Study period: 6 months
 
Close